Disclosure Of Entity's Operating Segments [Text Block]

BioInvent International - Filing #678852

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of entity's operating segments [text block]
RAPPORTERING FÖR SEGMENT  
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
71 461 SEK
326 126 SEK
Tax expense (income)
204,000 SEK
SEK
Profit (loss) before tax
330 100 SEK
42 503 SEK
Profit (loss)
330 304 SEK
330 304 SEK
42 503 SEK
42 503 SEK
Assets
1 400 180 SEK
1 712 214 SEK
Cash flows from (used in) operating activities
341 691 SEK
41 227 SEK
Cash flows from (used in) investing activities
59 681 SEK
628 848 SEK
Cash flows from (used in) financing activities
23 139 SEK
273 487 SEK
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.